The American chemical company Monsanto, purchased by Bayer, has again been ordered to pay high damages in the US for the weed killer Roundup, which contains glyphosate.
A jury in the city of Philadelphia on Friday awarded $2.25 billion to a plaintiff suffering from cancer, the man’s lawyer confirmed to the AFP news agency. The prosecutor, John McKivison, blamed Roundup for his cancer, called non-Hodgkin’s lymphoma.
Bayer told AFP it would appeal the verdict. The company denies that glyphosate is carcinogenic. The question has been controversial in science for years. In November, the European Commission extended the approval of the weedkiller for ten years.
Involved in legal proceedings since the takeover
Bayer acquired Roundup manufacturer Monsanto for $63 billion in 2018 and has since been embroiled in legal proceedings. The company was ordered to pay damages in a number of glyphosate cases, but was acquitted in other cases. Settlements have been reached in numerous cases.
According to Bayer, about 113,000 of the 160,000 cases filed by alleged victims have been completed to date. The group has set aside provisions worth $16 billion for this purpose. (sda/afp)
Soource :Watson
I am Amelia James, a passionate journalist with a deep-rooted interest in current affairs. I have more than five years of experience in the media industry, working both as an author and editor for 24 Instant News. My main focus lies in international news, particularly regional conflicts and political issues around the world.
